![Heidi Hunter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Heidi Hunter
Director/Board Member at
VICORE PHARMA HOLDING AB
Net worth: 6 601 $ as of 30/06/2026
Profile
Heidi Hunter is Vice Chairman at Bavarian Nordic A since 2025.
Ms. Hunter is Independent Director at Sutro Biopharma, Inc. since 2021.
Ms. Hunter is Independent Director at Vicore Pharma Holding AB since 2020.
Ms. Hunter was Independent Director at IO Biotech, Inc. from 2023 to 2026.
Ms. Hunter was Senior VP-Global Immunology Business Unit at UCB SA from 2015 to 2020.
Ms. Hunter was Senior Vice President & General Manager at Boehringer Ingelheim International GmbH from 2011 to 2015.
Ms. Hunter was Vice President at Centocor, Inc. Ms. Hunter was Vice President at IQVIA Partners A. Ms. Hunter was President at Cardinal Health Specialty Solutions from 2020 to 2022.
Ms. Hunter completed undergraduate studies at the University of Michigan.
Ms. Hunter earned an MBA from The University of Chicago Booth School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/12/2025 | 5,000 ( 0% ) | 6 510 $ | 30/06/2026 | |
IO BIOTECH, INC. 0.02% | 05/06/2025 | 15,000 ( 0.02% ) | 92 $ | 30/06/2026 |
| 05/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Heidi Hunter active positions
| Companies | Position | Start |
|---|---|---|
| VICORE PHARMA HOLDING AB | Director/Board Member | 01/01/2020 |
| SUTRO BIOPHARMA, INC. | Director/Board Member | 19/11/2021 |
| BAVARIAN NORDIC A/S | Director/Board Member | 01/01/2023 |
Former positions of Heidi Hunter
| Companies | Position | End |
|---|---|---|
| IO BIOTECH, INC. | Director/Board Member | 31/03/2026 |
Cardinal Health Specialty Solutions | President | 01/11/2022 |
| UCB | Corporate Officer/Principal | 01/09/2020 |
Boehringer Ingelheim International GmbH
 Boehringer Ingelheim International GmbH Pharmaceuticals: MajorHealth Technology Engages in development, manufacturing and marketing of medicines for humans & animals | Corporate Officer/Principal | 01/01/2015 |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products | Corporate Officer/Principal | - |
Training of Heidi Hunter
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
47
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products | Health Technology |
Sutro Biopharma, Inc.
 Sutro Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops new products in protein vaccines and therapeutics | Health Technology |
UCB SA
 UCB SA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Bavarian Nordic A/S
 Bavarian Nordic A/S BiotechnologyHealth Technology Engages in research, development and manufacturing travel vaccines | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IQVIA Partners A/S
 IQVIA Partners A/S Information Technology ServicesTechnology Services Operates an IT company | Technology Services |
Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH Pharmaceuticals: MajorHealth Technology Engages in development, manufacturing and marketing of medicines for humans & animals | Health Technology |
Vicore Pharma Holding AB
 Vicore Pharma Holding AB Pharmaceuticals: MajorHealth Technology Engages in research and development of drugs for lung diseases | Health Technology |
The University of Chicago Booth School of Business
 The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cardinal Health Specialty Solutions | |
IO Biotech, Inc.
 IO Biotech, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel, immune-modulating cancer therapies | Health Technology |
- Stock Market
- Insiders
- Heidi Hunter
Choose MarketScreener 
